This is the announcement released about Magna the global owner of Zolpimist exclusively licensing Zolpimist to AYTU for USA and Canada - nothing about the rest of the world which Magna licensed Suda
PERTH, AUSTRALIA – 15 June 2018: SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oromucosal drug delivery, today announced that Magna Pharmaceuticals, Inc., the globalowner of ZolpiMist (zolpidem tartrate oral spray), has exclusively licensed the product inthe USA and Canada to Englewood, Colorado-based, Aytu BioScience, Inc. (NASDAQ: AYTU).Aytu is an emerging specialty pharmaceutical company and will add ZolpiMist to its currentcommercial portfolio which includes a testosterone replacement nasal gel, Natesto
SUD Price at posting:
0.6¢ Sentiment: Hold Disclosure: Held